Navigation Links
Brain changes observed in people with sleep apnoea

Researchers in University of Boston observe that brain imaging sheds new light on the possible causes of sleep apnoea. In sleep apnoea, a person stops breathing, momentarily, many times during the night.// The cause is often a weakening of the muscles at the back of the throat, causing upper airway obstruction. Sleep apnoea is often linked with snoring and, naturally, causes daytime sleepiness. It may also be a risk factor for heart disease and stroke.

Researchers in the US have studied brain images from a group of 20 patients with sleep apnoea, comparing them with those from 20 healthy individuals. Those with the sleep disorder had an 15 per cent reduction in the grey matter volume in specific areas of the brain. These were the left frontal cortex, which controls upper airway function, and the cerebellum at the back of the brain, which controls heart and lung function. This raises the intriguing possibility that these changes may actually cause sleep apnoea, rather than resulting from the condition. In other words, the condition may have its origins in the brain.


'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. “Brain fingerprinting”- The new lie detectr
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Virus Combats Brain Tumour
6. Nasal Spray Could Take Drugs Directly to Brain
7. Control of anger disorder connected to Brain Dysfunction
8. High Levels of Protein Linked to Brain Shrinkage
9. Brain damage affects artistic skill
10. Brain cells protected by new compounds
11. Brain aneurysms can now be treated with a less invasive procedure
Post Your Comments:
(Date:10/7/2008)...g out of bed sooner helped quality of life after d...7 (HealthDay News) -- The best medicine for intens...ut of bed and moving as soon as they,re able, a ne...ent data, Johns Hopkins University School of Medic...deep sedation and bed rest may cause unnecessary a...
(Date:10/7/2008)...ikely to feel distress, more likely to enjoy bette...AY, Oct. 7 (HealthDay News) -- End-of-life discuss... do not result in more distress for patients. In f...entions and enhanced quality of life in a patient,...the past two decades, the debate has been around w...
(Date:10/7/2008)...DONA, Ariz., Oct. 7 /PRNewswire/ -- Join Mii amo, ...r-day celebration in Sedona,s red rock,country hon...es include a,series of traditional Native American... Director R.J. Joseph and special guest, Elder Geo... Blackfoot Elder from the Blood Reserve,in Standof...
(Date:10/7/2008)...U CLAIRE, Wis., Oct. 7 /PRNewswire/ -- Van Wert Co...st facility to go live with LOGICARE(R),Corp.,s ne...) EDIS., Van Wert County Hospital joins Conway Re...ern New Hampshire Medical Center, Nashua, New Hamp...mergency Departments., Van Wert County Hospital b...
Breaking Medicine News(10 mins):Health News:Early Mobility Best for ICU Patients 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Latest LOGICARE(R) EDIS User Sees 'Tremendous Results' 2
...n therapy with the new biologic drug adalimumab an...es more effective for people with long-standing rh...gement // with methotrexate alone. It has been fou...ents who fail to respond to standard treatment. A...
... Duke Univ. has shown that the surgical outcome of...n non-diabetics. The results were published Aug. 1...// In the largest analysis of its kind, Duke Univ... found that patients with diabetes who require sur...
...s had said that short-acting Beta-agonist (SABA) p...or asthma morbidity of steroid and non-steroid use...Illinois Medicaid, with a diagnosis of asthma from...esearchers from Chicago, IL, obtained the claims f...
...cer does not discriminate between rich and poor, i...ebrities have succumbed to it and some have fought...mous// actresses and personalities who have suffer...ton-John -Actress and SingerShirley Temple Black -...
Other Medicine News:Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 2Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 3
(Date:10/6/2008)... - Data Presented at ACG Annual Scient...ire/ -- Ironwood Pharmaceuticals,(formerly Microbi...r of,preclinical studies delineating the role that...leviating intestinal pain. These studies,demonstra...ical model of,intestinal hyperalgesia and desensit...
(Date:10/6/2008)... Experts Discuss Promising Research at The Amer... Annual Meeting, WASHINGTON, Oct. 6 /PRNewswir...n children and seniors was presented at The Americ...symposium, "Practical Applications of,Probiotics i...ields of,pediatrics, aging, and nutrition discusse...
(Date:10/6/2008)... PLYMOUTH MEETING, Pa., Oct. 6 /PRNewswire-Fi...oday reported data from its second Phase 1,clinica...d drug candidate,for the treatment of type 2 diabe...PTP1B, a validated molecular target that controls ...ys to normalize glucose and decrease,appetite. In ...
(Date:10/6/2008)... - Conference Call Scheduled for 9:0...tCall/ -- Dendreon Corporation (Nasdaq:,DNDN) anno...rim analysis of,the Phase 3, randomized, double-bl...Prostate AdenoCarcinoma Treatment, also known as D...y and efficacy of the,investigational active cellu...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 1Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 2Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 3Small Incisions Make Heart Valve Surgery Safer 918 1Small Incisions Make Heart Valve Surgery Safer 918 2Small Incisions Make Heart Valve Surgery Safer 918 3 26 239 3BDrug free treatments offer hope for older people in pain 915 1Medifast Announces Winners of Mother Daughter Challenge 912 1Medifast Announces Winners of Mother Daughter Challenge 912 2Medifast Announces Winners of Mother Daughter Challenge 912 3
...ested in Patients Reduces,Severity of Adult Leukae... the Danish,biopharmaceutical company, announced t...t of Bcl-2, has shown early evidence of,efficacy i...Lymphocytic Leukaemia (CLL). The results of the st...ting of the American Society of,Clinical Oncology,...
...7 - Inovio Biomedical,Corporation (AMEX:INO), focu... and infectious diseases and a novel alternative t...day the company,delivered multiple presentations o...ions relating to its electroporation-mediated DNA,...the American,Society of Gene Therapy (ASGT). Inovi...
Other Medicine Technology:Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 2Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 3Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 4Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 5
...ydroepiandrosterone sulfate (DHEA-S) is the sulfat...and by enzymatic conversion of DHEA in adrenal and...d secreted by the adrenal cortex, and is a precurs...A possesses relatively weak androgenic activity, w...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t
The SYNCHRON CX4 Delta Specialty / Drug Clinical System is a random access analyzer that can consolidate Drugs of Abuse, TDM's and other specialty testing, such as thyroid, HbA1c and lipids in one co
Medicine Products: